Status:

COMPLETED

Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls.

Lead Sponsor:

Kasr El Aini Hospital

Conditions:

Psoriasis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

A 4mm Punch biopsy is obtained from lesional and non lesional skin of 25 psoraitic patients as well as of 30 controls. Skin biopsy from patients (psoriasis lesional and non lesional) \& control will ...

Eligibility Criteria

Inclusion

  • patients with psoriasis vulgaris
  • patients over 18 years of age
  • both sexes

Exclusion

  • patients on treatment for psoriasis within the last two months
  • assoiciated autoimmune diseases eg SLE
  • pregnancy

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

55 Patients enrolled

Trial Details

Trial ID

NCT03767114

Start Date

January 1 2017

End Date

December 1 2018

Last Update

December 6 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls. | DecenTrialz